(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.

GUEST:
Jonas Oxgaard, Chemicals Equity Analyst at Sanford Bernstein, weighs in on Bayer AG's bid for Monsanto: he's not optimistic the deal will go through.

<p>(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox.

GUEST:
Jonas Oxgaard, Chemicals Equity Analyst at Sanford Bernstein, weighs in on Bayer AG's bid for Monsanto: he's not optimistic the deal will go through.</p>

Scarlet Fu and Paul Sweeney harness the power of Bloomberg Intelligence to analyze market news and provide in-depth company research. Watch us LIVE on YouTube: http://bit.ly/3vTiACF.

<p>Scarlet Fu and Paul Sweeney harness the power of Bloomberg Intelligence to analyze market news and provide in-depth company research. Watch us LIVE on YouTube: <a href="http://bit.ly/3vTiACF">http://bit.ly/3vTiACF</a>.</p>

Alix Steel and Paul Sweeney harness the power of Bloomberg Intelligence to analyze markets, companies and industries.

Bloomberg Intelligence

Sanford’s Oxgaard: Not Optimistic on Bayer-Monsanto Deal(Audio)

Sanford's Oxgaard: Not Optimistic on Bayer-Monsanto Deal(Audio)

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/655b6ee0-a2e2-4acb-b38a-ae3c00aa32da/transcript

Advertisement